Skip to main content

Table 1 Baseline features of eyes with steroid associated CSC (group A) and those with idiopathic CSC (group B)

From: Retinal and choroidal changes in steroid-associated central serous chorioretinopathy

Baseline features Group A (N = 20 eyes of 16 patients) Group A (N = 30 eyes of 28 patients) P value
Age (years ± SD) 45 ± 16.13 43.3 ± 9.45 0.77
Male: female (n) 12:8 5:25 < 0.01*
Bilaterality 6/20 (30%) 2/30 (6.67%) 0.03*
Duration of symptoms (days ± SD) 105.83 ± 96.10 107.13 ± 138.70 0.98
Baseline BCVA (Snellen ± SD logMAR) 20/33 ± 0.34 20/40 ± 0.27 0.06
  1. CSC central serous chorioretinopathy; SD standard deviation; BCVA best corrected visual acuity
  2. * Statistically significant